Latest Commercialization News

Fortescue Metals Group delivered record iron ore shipments in FY25 alongside a rare cost decline, while recalibrating its green energy ambitions and maintaining a strong financial position.

PEXA’s UK arm has secured a formal commitment from NatWest to implement its digital platform for remortgage and sale & purchase transactions, marking a pivotal step in PEXA’s UK expansion.

Calix Limited has secured a $44.9 million grant from ARENA to build a pioneering Green Iron Demonstration Plant using its ZESTY technology, aiming to produce 30,000 tonnes of low-emission iron annually and advance Australia’s green steel ambitions.

Adisyn Ltd has made significant strides in developing low-temperature graphene semiconductor interconnects, commissioning a new Atomic Layer Deposition system and securing a major managed IT services contract, while maintaining a strong cash position.

Lynas Rare Earths has achieved record quarterly production of key rare earth elements and reported a strong 38% increase in sales revenue, while advancing its Mt Weld expansion and signing strategic MOUs in Malaysia.

Hiremii Limited reported a 4.4% revenue increase in Q4 FY25 alongside positive operating cash flow, while accelerating commercialisation of its proprietary AI recruitment platform and expanding through a key acquisition.

Tungsten Mining NL (ASX – TGN) highlights its position as a key supplier of ethically sourced tungsten outside China, leveraging one of the world’s largest resource bases amid tightening global supply and rising prices.

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.

Patrys Limited has launched a fully underwritten entitlement offer to raise approximately $1.77 million, aiming to accelerate development and commercial activities around its deoxymabs program.

Mindax Limited has secured an option to acquire Norton Goldfields’ 35% stake in the Mt Forrest magnetite project, potentially gaining full ownership of a major iron ore asset in Western Australia’s Mid-West region.

Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.

Pilot Energy has initiated a formal farmout process to attract partners for its offshore Perth Basin permit WA-481P, featuring the ready-to-drill Leander Gas Prospect with 1.1 trillion cubic feet of prospective gas resources.